United States DTC Wellness Testing Market is expected to grow with an impressive CAGR in the forecast period 2024-2028. United States DTC Wellness Testing Market is growing on the account of growing awareness
DTC Wellness testing when performed for genetic testing, provides consumer access to genetic information and enhanced privacy of information.
One of the key drivers of this growth has been the increasing consumer demand for personalized and accessible healthcare solutions. With DTC wellness testing, consumers can easily order and receive tests to track various health indicators, such as hormone levels, vitamin deficiencies, and genetic predispositions to certain diseases.
Moreover, United States Healthcare industry is growing and expanding its outreach by moving towards precision care, propelled by advanced testing and result analysis, among the population, increasing consumer demand for convenient and affordable healthcare options, rising healthcare costs, etc. The introduction of DTC Wellness in United States healthcare is offering access to get personalized medical treatments for citizens, based on their genomic data so that people could have more control over their own health.
The factors that influence the growth of United States DTC wellness testing market includes technological advancements, personalized healthcare, and increasing awareness of preventive healthcare.
Growing Awareness and Advantages of DTC Wellness Testing
Direct-To-Consumer (DTC) provides access of genetic information to the customers directly and without the interference of a healthcare provider or any health insurance company. The growing awareness about wellness testing is creating a huge demand for DTC Wellness testing market among the population in case of rising demand for DTC-wellness Testing offerings such as home health & wellness kits. Major disease testing performed by collecting samples at home for determining diseases such as infectious diseases like human papillomavirus, syphilis, HIV, and hepatitis C are increasing the demand for collection kits. Additionally, with a growing emphasis on preventive healthcare, more consumers are turning to DTC wellness testing as a way to monitor their health and identify potential health issues early on. Moreover, DTC wellness testing allows consumers to order and receive laboratory tests without the need for a healthcare provider's order or involvement, providing a convenient and affordable option for preventive healthcare.
Growing Accessibility to Genetic Testing like Molecular Testing
DTC wellness testing market finds important applications in genetic testing by providing genetic tests to the consumers directly, without the inclusion of a healthcare provider and thus, is gaining popularity for several advantages. DTC genetic testing can be performed to identify arrangement of DNA in chromosome, to identifying portions of genomes, and also involves performing comprehensive DNA sequencing of specific genes to look for any specific changes that may cause disease in the person. DTC Testing is advantageous in family planning as it helps in identifying any chromosomal abnormality present in the fetus. DTC genetic testing kits can provide paternity testing ease, by providing accuracy by sample collection at home and avoid contamination. Moreover, the DTC (direct-to-consumer (DTC) genetic testing proves itself to be an efficient method to make a person’s medical genetic information found at to the consumers and thus is an efficient tool to help avoid genetic discrimination by avoiding the patient’s genetic information in medical records.
Growing Demand in Cancer Susceptibility
The growing prevalence of cancer has increased the demand for testing methods that aid in pre-diagnosing cancer in the patients, in early stages. DTC Genetic testing is helpful in patients that suspect risk of cancer such as breast cancer and are susceptible to getting the risk of breast cancer. Due to the health guidelines by the United States healthcare system, the physicians are required to follow guidelines to perform genetic testing for cancer suspects and thus are restricted to perform the testing in limited numbers and also cannot clear doubt in a person suffering from the doubt of acquiring cancer. In such scenarios, one can get reassurance by getting DTC testing which is advantageous to the person and may help in identifying mutations in the breast cancer susceptibility genes BRCA1 and BRCA2. Therefore, this aspect of the US DTC Wellness Testing market is helping to support the market growth, in the forecast period.
Growing Public Awareness and Demand for Transparency in Performing Testing
DTC testing is comparably performed at a lesser expense and faster pace than genetic testing. For instance, in DTC genetic testing kits, the sample is collected non-invasively by methods such as collecting saliva or swabbing inside the mouth by cotton swabs, taking blood samples, etc.
Furthermore, consumers can obtain the information related to their results quickly and precisely, through the DTC testing company’s online portal. Thus, it increases the demand for consumer’s privacy and provide genetic database to the consumer directly, thereby leading to build an increased demand for United States DTC wellness testing market in the forecast period. The companies also started marketing diagnostic and serological COVID-19 tests directly to consumers in the middle of the pandemic. The sample was collected from the patient at home or sent to the laboratory, with negligible involvement of the healthcare provider. The majority of the companies received emergency use authorization (EUA) for such testing. The companies are forming strategic partnerships with some e-commerce giants. For instance, in September 2021, a market player namely Nordstrom collaborated with Viome Life Sciences, Inc. to take up its wellness category under a new-brand retail partnership. The company aims to sell Viome's health intelligence test online and expand distribution in the selected retailers by 2022.
Recent Developments
- InMarch 2021, a binding merger agreement between 23andMe, Inc. and VG AcquisitionCorp. was signed. Due to this corporate merger, the company now has a $3,500million market value.
- InOctober 2021, the market players like Everlywell, Inc. acquired Natalist, abusiness that sells clients necessities for conception and pregnancy. DTChealth products from Everlywell, Inc. include prenatal vitamins, ovulationtesting, and pregnancy tests.
- InMarch 2021, Everlywell, Inc. purchased PWNHealth and Home Access HealthCorporation and subsequently established the parent business, Everly Health.More than 20 million people are supported by these businesses annually acrossall 50 U.S. states, Canada, and Puerto Rico.
Market Segmentation
The United States DTC Wellness Testing Market is segmented based on Test Type, Offerings, Distribution Channel, Sample Type and Region. Based on Test Type, the market is segmented into Hormone, Micronutrients, Food Intolerance, Food Sensitivity, COVID-19 DTC Test, Infectious Disease Tests and Others. Depending on the offerings, the market is segmented into Test Panel, Test Strips, Digital Monitoring Instruments, and Other), Based on Distribution Channel, the market is segmented into Online and Over the Counter. Based on Sample Type, the marketed is segmented into Blood, Urine, Saliva and Other. Based on the region, the Market is further segmented into Southern U.S., Midwest U.S., Mid-Atlantic U.S., West U.S., Southwest U.S., and New England.
Market Players
23andMe Inc., Everlywell, Inc., Quest Diagnostics, LetsGetChecked (PrivaPath Diagnostics Ltd.), Kindbody, Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Cue., myLAB Box., Ro (Modern Fertility), etc., are some of the major players operating in the United States DTC Wellness Testing Market.
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in United States Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Test Type Offerings Distribution channel Sample type |
Country Scope | Northeast, Midwest, South, West |
Key Companies Profiled | 23andMe Inc., Everlywell, Inc., Quest Diagnostics, LetGetChecked (PrivaPath Diagnostics Ltd.), Kindbody, Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Cue., myLAB Box., Ro (Modern Fertility). |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |